Default: Gut

ISSN: 0017-5749

Journal Home

Journal Guideline

Gut Q1 Unclaimed

BMJ Publishing Group United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Gut is a journal indexed in SJR in Gastroenterology with an H index of 348. It has a price of 2083 €. It has an SJR impact factor of 8,052 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 8,052.

Gut focuses its scope in these topics and keywords: disease, patients, coeliac, chronic, cancer, cell, liver, hepatitis, human, outcome, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Scopus WOS
Categories: Gastroenterology (Q1)

2083 €

Inmediate OA


Embargoed OA

0 €

Non OA




SJR Impact factor


H Index


Total Docs (Last Year)


Total Docs (3 years)


Total Refs


Total Cites (3 years)


Citable Docs (3 years)


Cites/Doc (2 years)




No comments ... Be the first to comment!

Aims and Scope

disease, patients, coeliac, chronic, cancer, cell, liver, hepatitis, human, outcome, colonic, hepatic, hepatocellular, polyposis, clinical, carcinoma, year, syndrome, role, cirrhosis, population, pancreatic, intestinal, infection,

Best articles by citations

The intestinal brush border

View more

Bax is downregulated in inflamed colonic mucosa of ulcerative colitis

View more

Compared with parenteral nutrition, enteral feeding attenuates the acute phase response and improves disease severity in acute pancreatitis

View more

PWE-005 Outcomes from the first uk bowel cancer screening programme (bcsp) site: screening and surveillance experience since 2006

View more

Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease

View more

Probiotics in inflammatory bowel disease: is it all gut flora modulation?

View more

Antibodies to human gastric epithelial cells and heat shock protein 60 in Helicobacter pylori positive mucosa associated lymphoid tissue lymphoma

View more

-Glucosylceramide: a novel method for enhancement of natural killer T lymphoycte plasticity in murine models of immune-mediated disorders

View more

Do different patients with coeliac disease have different mortality rates?

View more

Helicobacter pylori specific nested PCR assay for the detection of 23S rRNA mutation associated with clarithromycin resistance

View more

C reactive protein and prealbumin as markers of disease activity in shigellosis.

View more

PCR detection of Mycobacterium paratuberculosis in Crohn's disease granulomas isolated by laser capture microdissection

View more

Urea breath tests in the management of Helicobacter pylori infection

View more

Comparison of serum, salivary, and rapid whole blood diagnostic tests for Helicobacter pylori and their validation against endoscopy based tests.

View more

Heterogeneity in responses by primary adult human colonic epithelial cells to purified enterotoxin of Bacteroides fragilis

View more

The first recorded case of Whipple's disease?

View more

The incidence and risks of liver biopsy in non-cirrhotic patients: An evaluation of 3806 biopsies

View more

"Non-invasive investigation of gastrointestinal functions with magnetic resonance imaging: towards an ""ideal"" investigation of gastrointestinal function"

View more

Evaluation of a novel monoclonal enzyme immunoassay for detection of Helicobacter pylori antigen in stool from children

View more

Epidemiology of fibrolamellar hepatocellular carcinoma in the USA, 2000-10

View more

Antibody (IgG, IgA, and IgM) to baker's yeast (Saccharomyces cerevisiae), yeast mannan, gliadin, ovalbumin and betalactoglobulin in monozygotic twins with inflammatory bowel disease.

View more

Causes of death in people with coeliac disease in England compared with the general population: a competing risk analysis

View more

Endomysial antibody-negative coeliac disease: clinical characteristics and intestinal autoantibody deposits

View more

NOD2 (CARD15), the first susceptibility gene for Crohn's disease

View more